Profile
| Metric | Value |
|---|---|
| Full Name | RadNet, Inc. |
| Ticker | NASDAQ: RDNT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | radnet.com |
| Employees | 11,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $78.38 | |
| Price, 1D Change | +1.25% | |
| Market Cap | $6B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.07 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +13.18% | |
| EPS | $0.04 | |
| EPS, 1Y Change | -20.59% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PMDX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.04 | |
| EPS Estimate | $0.37 | |
| EPS Est. Change | +898.13% | |
| Revenue | $1.83B | |
| Revenue Estimate | $2.01B | |
| Revenue Est. Change | +9.74% | |
| Current Price | $78.38 | |
| Price Target | - | $91.00 |
| Price Tgt. Change | - | +16.10% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.46 | $0.05 | -89.76% | |
| $0.62 | $0.04 | -93.99% | |
| $0.37 | N/A | +898.13% | |
| $0.78 | N/A | +1,981.02% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.61B | $1.62B | +0.64% | |
| $1.81B | $1.83B | +0.98% | |
| $2.01B | N/A | +9.74% | |
| $2.22B | N/A | +21.29% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +8.48% | |
| Price, 3Y | +318.25% | |
| Market Cap, 1Y | +13.04% | |
| Market Cap, 3Y | +458.99% | |
| Revenue, 1Y | +13.18% | |
| Revenue, 3Y | +39.13% | |
| EPS, 1Y | -20.59% | |
| EPS, 3Y | -91.92% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $78.38 | |
| SMA 200 | $65.66 | |
| SMA 200 vs Price | -16.23% | |
| SMA 50 | $76.92 | |
| SMA 50 vs Price | -1.86% | |
| Beta | 1.07 | |
| ATR | $2.92 | |
| 14-Day RSI | 58.39 | |
| 10-Day Volatility | 32.96% | |
| 1-Year Volatility | 44.38% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.83B | |
| EPS | $0.04 | |
| Gross Profit | $111.28M | |
| Gross Margin | 6.08% | |
| Operating Profit | $111.28M | |
| Operating Margin | 6.08% | |
| Net Income | $38.84M | |
| Net Margin | 2.12% | |
| EBITDA | $249.12M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.92 | |
| Current Ratio | 2.12 | |
| Quick Ratio | 2.12 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 2.32 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 3.07 | |
| PB Ratio | 5.71 | |
| EV/EBITDA | 30.78 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $902.31M | |
| Cash & Equivalents | $740.02M | |
| Total Assets | $3.50B | |
| Current Assets | $1.02B | |
| Total Liabilities | $2.36B | |
| Current Liabilities | $479.71M | |
| Total Debt | $1.73B | |
| Short Term Debt | $81.31M | |
| Accounts Payable | $96.45M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.83B | |
| Operating Expenses | $0.00 | |
| Cost Of Goods Sold | $1.72B | |
| SG&A | $0.00 | |
| D&A | $137.84M | |
| Interest Expense | $0.00 | |
| Income Tax | $6.03M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $233.02M | |
| CFI | -$210.71M | |
| CFF | $375.59M | |
| Capex | $188.07M | |
| Free Cash Flow | $44.95M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B. Riley Securities | → | |
| Barclays | → | |
| Truist Securities | → | |
| Truist Securities | → | |
| Barclays | → | |
| Raymond James | → | |
| B. Riley Securities | ||
| Truist Securities | → | |
| Barclays | → | |
| Raymond James | → |
Analyst sentiment
Institutional ownership
Screeners with RDNT
Data Sources & References
- RDNT Official Website www.radnet.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/790526/000079052625000008/0000790526-25-000008-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/790526/000162828025009481/0001628280-25-009481-index.htm
- RDNT Profile on Yahoo Finance finance.yahoo.com/quote/RDNT
- RDNT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdnt
FAQ
What is the ticker symbol for RadNet, Inc.?
The ticker symbol for RadNet, Inc. is NASDAQ:RDNT
Does RadNet, Inc. pay dividends?
No, RadNet, Inc. does not pay dividends
What sector is RadNet, Inc. in?
RadNet, Inc. is in the Healthcare sector
What industry is RadNet, Inc. in?
RadNet, Inc. is in the Diagnostics & Research industry
What country is RadNet, Inc. based in?
RadNet, Inc. is headquartered in United States
When did RadNet, Inc. go public?
RadNet, Inc. initial public offering (IPO) was on January 3, 1997
Is RadNet, Inc. in the S&P 500?
No, RadNet, Inc. is not included in the S&P 500 index
Is RadNet, Inc. in the NASDAQ 100?
No, RadNet, Inc. is not included in the NASDAQ 100 index
Is RadNet, Inc. in the Dow Jones?
No, RadNet, Inc. is not included in the Dow Jones index
When was RadNet, Inc. last earnings report?
RadNet, Inc.'s most recent earnings report was on November 9, 2025
When does RadNet, Inc. report earnings?
The next expected earnings date for RadNet, Inc. is February 26, 2026